Global Nuclear Medicine Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Nuclear Medicine market size is predicted to grow from US$ 7067 million in 2025 to US$ 11010 million in 2031; it is expected to grow at a CAGR of 7.7% from 2025 to 2031.
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
LPI (LP Information)' newest research report, the “Nuclear Medicine Industry Forecast” looks at past sales and reviews total world Nuclear Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine sales for 2025 through 2031. With Nuclear Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nuclear Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Nuclear Medicine market size is predicted to grow from US$ 7067 million in 2025 to US$ 11010 million in 2031; it is expected to grow at a CAGR of 7.7% from 2025 to 2031.
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
LPI (LP Information)' newest research report, the “Nuclear Medicine Industry Forecast” looks at past sales and reviews total world Nuclear Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine sales for 2025 through 2031. With Nuclear Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nuclear Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Diagnostic Nuclear Medicine
- Therapeutic Nuclear Medicine
- Oncology
- Thyroid
- Cardiology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cardinal Health
- GE Healthcare
- Jubilant Pharma
- Novartis
- Curium Pharma
- SIEMENS
- Lantheus
- Bracco Imaging
- Bayer
- Eli Lilly
- Aurobindo Pharma
- Mundipharma
- China Isotope & Radiation
- Yantai Dongcheng
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Market Size (2020-2031)
2.1.2 Nuclear Medicine Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nuclear Medicine by Country/Region (2020, 2024 & 2031)
2.2 Nuclear Medicine Segment by Type
2.2.1 Diagnostic Nuclear Medicine
2.2.2 Therapeutic Nuclear Medicine
2.3 Nuclear Medicine Market Size by Type
2.3.1 Nuclear Medicine Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nuclear Medicine Market Size Market Share by Type (2020-2025)
2.4 Nuclear Medicine Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.4.4 Others
2.5 Nuclear Medicine Market Size by Application
2.5.1 Nuclear Medicine Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nuclear Medicine Market Size Market Share by Application (2020-2025)
3 NUCLEAR MEDICINE MARKET SIZE BY PLAYER
3.1 Nuclear Medicine Market Size Market Share by Player
3.1.1 Global Nuclear Medicine Revenue by Player (2020-2025)
3.1.2 Global Nuclear Medicine Revenue Market Share by Player (2020-2025)
3.2 Global Nuclear Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE BY REGION
4.1 Nuclear Medicine Market Size by Region (2020-2025)
4.2 Global Nuclear Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nuclear Medicine Market Size Growth (2020-2025)
4.4 APAC Nuclear Medicine Market Size Growth (2020-2025)
4.5 Europe Nuclear Medicine Market Size Growth (2020-2025)
4.6 Middle East & Africa Nuclear Medicine Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nuclear Medicine Market Size by Country (2020-2025)
5.2 Americas Nuclear Medicine Market Size by Type (2020-2025)
5.3 Americas Nuclear Medicine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Market Size by Region (2020-2025)
6.2 APAC Nuclear Medicine Market Size by Type (2020-2025)
6.3 APAC Nuclear Medicine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nuclear Medicine Market Size by Country (2020-2025)
7.2 Europe Nuclear Medicine Market Size by Type (2020-2025)
7.3 Europe Nuclear Medicine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine by Region (2020-2025)
8.2 Middle East & Africa Nuclear Medicine Market Size by Type (2020-2025)
8.3 Middle East & Africa Nuclear Medicine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEAR MEDICINE MARKET FORECAST
10.1 Global Nuclear Medicine Forecast by Region (2026-2031)
10.1.1 Global Nuclear Medicine Forecast by Region (2026-2031)
10.1.2 Americas Nuclear Medicine Forecast
10.1.3 APAC Nuclear Medicine Forecast
10.1.4 Europe Nuclear Medicine Forecast
10.1.5 Middle East & Africa Nuclear Medicine Forecast
10.2 Americas Nuclear Medicine Forecast by Country (2026-2031)
10.2.1 United States Market Nuclear Medicine Forecast
10.2.2 Canada Market Nuclear Medicine Forecast
10.2.3 Mexico Market Nuclear Medicine Forecast
10.2.4 Brazil Market Nuclear Medicine Forecast
10.3 APAC Nuclear Medicine Forecast by Region (2026-2031)
10.3.1 China Nuclear Medicine Market Forecast
10.3.2 Japan Market Nuclear Medicine Forecast
10.3.3 Korea Market Nuclear Medicine Forecast
10.3.4 Southeast Asia Market Nuclear Medicine Forecast
10.3.5 India Market Nuclear Medicine Forecast
10.3.6 Australia Market Nuclear Medicine Forecast
10.4 Europe Nuclear Medicine Forecast by Country (2026-2031)
10.4.1 Germany Market Nuclear Medicine Forecast
10.4.2 France Market Nuclear Medicine Forecast
10.4.3 UK Market Nuclear Medicine Forecast
10.4.4 Italy Market Nuclear Medicine Forecast
10.4.5 Russia Market Nuclear Medicine Forecast
10.5 Middle East & Africa Nuclear Medicine Forecast by Region (2026-2031)
10.5.1 Egypt Market Nuclear Medicine Forecast
10.5.2 South Africa Market Nuclear Medicine Forecast
10.5.3 Israel Market Nuclear Medicine Forecast
10.5.4 Turkey Market Nuclear Medicine Forecast
10.6 Global Nuclear Medicine Forecast by Type (2026-2031)
10.7 Global Nuclear Medicine Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nuclear Medicine Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cardinal Health
11.1.1 Cardinal Health Company Information
11.1.2 Cardinal Health Nuclear Medicine Product Offered
11.1.3 Cardinal Health Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Cardinal Health Main Business Overview
11.1.5 Cardinal Health Latest Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Information
11.2.2 GE Healthcare Nuclear Medicine Product Offered
11.2.3 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 GE Healthcare Main Business Overview
11.2.5 GE Healthcare Latest Developments
11.3 Jubilant Pharma
11.3.1 Jubilant Pharma Company Information
11.3.2 Jubilant Pharma Nuclear Medicine Product Offered
11.3.3 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Jubilant Pharma Main Business Overview
11.3.5 Jubilant Pharma Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Nuclear Medicine Product Offered
11.4.3 Novartis Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Curium Pharma
11.5.1 Curium Pharma Company Information
11.5.2 Curium Pharma Nuclear Medicine Product Offered
11.5.3 Curium Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Curium Pharma Main Business Overview
11.5.5 Curium Pharma Latest Developments
11.6 SIEMENS
11.6.1 SIEMENS Company Information
11.6.2 SIEMENS Nuclear Medicine Product Offered
11.6.3 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 SIEMENS Main Business Overview
11.6.5 SIEMENS Latest Developments
11.7 Lantheus
11.7.1 Lantheus Company Information
11.7.2 Lantheus Nuclear Medicine Product Offered
11.7.3 Lantheus Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Lantheus Main Business Overview
11.7.5 Lantheus Latest Developments
11.8 Bracco Imaging
11.8.1 Bracco Imaging Company Information
11.8.2 Bracco Imaging Nuclear Medicine Product Offered
11.8.3 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bracco Imaging Main Business Overview
11.8.5 Bracco Imaging Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Nuclear Medicine Product Offered
11.9.3 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Nuclear Medicine Product Offered
11.10.3 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Information
11.11.2 Aurobindo Pharma Nuclear Medicine Product Offered
11.11.3 Aurobindo Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Aurobindo Pharma Main Business Overview
11.11.5 Aurobindo Pharma Latest Developments
11.12 Mundipharma
11.12.1 Mundipharma Company Information
11.12.2 Mundipharma Nuclear Medicine Product Offered
11.12.3 Mundipharma Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Mundipharma Main Business Overview
11.12.5 Mundipharma Latest Developments
11.13 China Isotope & Radiation
11.13.1 China Isotope & Radiation Company Information
11.13.2 China Isotope & Radiation Nuclear Medicine Product Offered
11.13.3 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 China Isotope & Radiation Main Business Overview
11.13.5 China Isotope & Radiation Latest Developments
11.14 Yantai Dongcheng
11.14.1 Yantai Dongcheng Company Information
11.14.2 Yantai Dongcheng Nuclear Medicine Product Offered
11.14.3 Yantai Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Yantai Dongcheng Main Business Overview
11.14.5 Yantai Dongcheng Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Market Size (2020-2031)
2.1.2 Nuclear Medicine Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nuclear Medicine by Country/Region (2020, 2024 & 2031)
2.2 Nuclear Medicine Segment by Type
2.2.1 Diagnostic Nuclear Medicine
2.2.2 Therapeutic Nuclear Medicine
2.3 Nuclear Medicine Market Size by Type
2.3.1 Nuclear Medicine Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nuclear Medicine Market Size Market Share by Type (2020-2025)
2.4 Nuclear Medicine Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.4.4 Others
2.5 Nuclear Medicine Market Size by Application
2.5.1 Nuclear Medicine Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nuclear Medicine Market Size Market Share by Application (2020-2025)
3 NUCLEAR MEDICINE MARKET SIZE BY PLAYER
3.1 Nuclear Medicine Market Size Market Share by Player
3.1.1 Global Nuclear Medicine Revenue by Player (2020-2025)
3.1.2 Global Nuclear Medicine Revenue Market Share by Player (2020-2025)
3.2 Global Nuclear Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE BY REGION
4.1 Nuclear Medicine Market Size by Region (2020-2025)
4.2 Global Nuclear Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nuclear Medicine Market Size Growth (2020-2025)
4.4 APAC Nuclear Medicine Market Size Growth (2020-2025)
4.5 Europe Nuclear Medicine Market Size Growth (2020-2025)
4.6 Middle East & Africa Nuclear Medicine Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nuclear Medicine Market Size by Country (2020-2025)
5.2 Americas Nuclear Medicine Market Size by Type (2020-2025)
5.3 Americas Nuclear Medicine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Market Size by Region (2020-2025)
6.2 APAC Nuclear Medicine Market Size by Type (2020-2025)
6.3 APAC Nuclear Medicine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nuclear Medicine Market Size by Country (2020-2025)
7.2 Europe Nuclear Medicine Market Size by Type (2020-2025)
7.3 Europe Nuclear Medicine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine by Region (2020-2025)
8.2 Middle East & Africa Nuclear Medicine Market Size by Type (2020-2025)
8.3 Middle East & Africa Nuclear Medicine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEAR MEDICINE MARKET FORECAST
10.1 Global Nuclear Medicine Forecast by Region (2026-2031)
10.1.1 Global Nuclear Medicine Forecast by Region (2026-2031)
10.1.2 Americas Nuclear Medicine Forecast
10.1.3 APAC Nuclear Medicine Forecast
10.1.4 Europe Nuclear Medicine Forecast
10.1.5 Middle East & Africa Nuclear Medicine Forecast
10.2 Americas Nuclear Medicine Forecast by Country (2026-2031)
10.2.1 United States Market Nuclear Medicine Forecast
10.2.2 Canada Market Nuclear Medicine Forecast
10.2.3 Mexico Market Nuclear Medicine Forecast
10.2.4 Brazil Market Nuclear Medicine Forecast
10.3 APAC Nuclear Medicine Forecast by Region (2026-2031)
10.3.1 China Nuclear Medicine Market Forecast
10.3.2 Japan Market Nuclear Medicine Forecast
10.3.3 Korea Market Nuclear Medicine Forecast
10.3.4 Southeast Asia Market Nuclear Medicine Forecast
10.3.5 India Market Nuclear Medicine Forecast
10.3.6 Australia Market Nuclear Medicine Forecast
10.4 Europe Nuclear Medicine Forecast by Country (2026-2031)
10.4.1 Germany Market Nuclear Medicine Forecast
10.4.2 France Market Nuclear Medicine Forecast
10.4.3 UK Market Nuclear Medicine Forecast
10.4.4 Italy Market Nuclear Medicine Forecast
10.4.5 Russia Market Nuclear Medicine Forecast
10.5 Middle East & Africa Nuclear Medicine Forecast by Region (2026-2031)
10.5.1 Egypt Market Nuclear Medicine Forecast
10.5.2 South Africa Market Nuclear Medicine Forecast
10.5.3 Israel Market Nuclear Medicine Forecast
10.5.4 Turkey Market Nuclear Medicine Forecast
10.6 Global Nuclear Medicine Forecast by Type (2026-2031)
10.7 Global Nuclear Medicine Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nuclear Medicine Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cardinal Health
11.1.1 Cardinal Health Company Information
11.1.2 Cardinal Health Nuclear Medicine Product Offered
11.1.3 Cardinal Health Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Cardinal Health Main Business Overview
11.1.5 Cardinal Health Latest Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Information
11.2.2 GE Healthcare Nuclear Medicine Product Offered
11.2.3 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 GE Healthcare Main Business Overview
11.2.5 GE Healthcare Latest Developments
11.3 Jubilant Pharma
11.3.1 Jubilant Pharma Company Information
11.3.2 Jubilant Pharma Nuclear Medicine Product Offered
11.3.3 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Jubilant Pharma Main Business Overview
11.3.5 Jubilant Pharma Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Nuclear Medicine Product Offered
11.4.3 Novartis Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Curium Pharma
11.5.1 Curium Pharma Company Information
11.5.2 Curium Pharma Nuclear Medicine Product Offered
11.5.3 Curium Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Curium Pharma Main Business Overview
11.5.5 Curium Pharma Latest Developments
11.6 SIEMENS
11.6.1 SIEMENS Company Information
11.6.2 SIEMENS Nuclear Medicine Product Offered
11.6.3 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 SIEMENS Main Business Overview
11.6.5 SIEMENS Latest Developments
11.7 Lantheus
11.7.1 Lantheus Company Information
11.7.2 Lantheus Nuclear Medicine Product Offered
11.7.3 Lantheus Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Lantheus Main Business Overview
11.7.5 Lantheus Latest Developments
11.8 Bracco Imaging
11.8.1 Bracco Imaging Company Information
11.8.2 Bracco Imaging Nuclear Medicine Product Offered
11.8.3 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bracco Imaging Main Business Overview
11.8.5 Bracco Imaging Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Nuclear Medicine Product Offered
11.9.3 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Nuclear Medicine Product Offered
11.10.3 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Information
11.11.2 Aurobindo Pharma Nuclear Medicine Product Offered
11.11.3 Aurobindo Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Aurobindo Pharma Main Business Overview
11.11.5 Aurobindo Pharma Latest Developments
11.12 Mundipharma
11.12.1 Mundipharma Company Information
11.12.2 Mundipharma Nuclear Medicine Product Offered
11.12.3 Mundipharma Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Mundipharma Main Business Overview
11.12.5 Mundipharma Latest Developments
11.13 China Isotope & Radiation
11.13.1 China Isotope & Radiation Company Information
11.13.2 China Isotope & Radiation Nuclear Medicine Product Offered
11.13.3 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 China Isotope & Radiation Main Business Overview
11.13.5 China Isotope & Radiation Latest Developments
11.14 Yantai Dongcheng
11.14.1 Yantai Dongcheng Company Information
11.14.2 Yantai Dongcheng Nuclear Medicine Product Offered
11.14.3 Yantai Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Yantai Dongcheng Main Business Overview
11.14.5 Yantai Dongcheng Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Medicine Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nuclear Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Diagnostic Nuclear Medicine
Table 4. Major Players of Therapeutic Nuclear Medicine
Table 5. Nuclear Medicine Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Nuclear Medicine Market Size Market Share by Type (2020-2025)
Table 8. Nuclear Medicine Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Nuclear Medicine Market Size Market Share by Application (2020-2025)
Table 11. Global Nuclear Medicine Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Nuclear Medicine Revenue Market Share by Player (2020-2025)
Table 13. Nuclear Medicine Key Players Head office and Products Offered
Table 14. Nuclear Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nuclear Medicine Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Nuclear Medicine Market Size Market Share by Region (2020-2025)
Table 19. Global Nuclear Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Nuclear Medicine Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Nuclear Medicine Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Nuclear Medicine Market Size Market Share by Country (2020-2025)
Table 23. Americas Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Nuclear Medicine Market Size Market Share by Type (2020-2025)
Table 25. Americas Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Nuclear Medicine Market Size Market Share by Application (2020-2025)
Table 27. APAC Nuclear Medicine Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Nuclear Medicine Market Size Market Share by Region (2020-2025)
Table 29. APAC Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Nuclear Medicine Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Nuclear Medicine Market Size Market Share by Country (2020-2025)
Table 33. Europe Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Nuclear Medicine Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Nuclear Medicine
Table 39. Key Market Challenges & Risks of Nuclear Medicine
Table 40. Key Industry Trends of Nuclear Medicine
Table 41. Global Nuclear Medicine Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Nuclear Medicine Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Nuclear Medicine Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Nuclear Medicine Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Cardinal Health Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 46. Cardinal Health Nuclear Medicine Product Offered
Table 47. Cardinal Health Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Cardinal Health Main Business
Table 49. Cardinal Health Latest Developments
Table 50. GE Healthcare Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 51. GE Healthcare Nuclear Medicine Product Offered
Table 52. GE Healthcare Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. GE Healthcare Main Business
Table 54. GE Healthcare Latest Developments
Table 55. Jubilant Pharma Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 56. Jubilant Pharma Nuclear Medicine Product Offered
Table 57. Jubilant Pharma Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Jubilant Pharma Main Business
Table 59. Jubilant Pharma Latest Developments
Table 60. Novartis Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 61. Novartis Nuclear Medicine Product Offered
Table 62. Novartis Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Curium Pharma Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 66. Curium Pharma Nuclear Medicine Product Offered
Table 67. Curium Pharma Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Curium Pharma Main Business
Table 69. Curium Pharma Latest Developments
Table 70. SIEMENS Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 71. SIEMENS Nuclear Medicine Product Offered
Table 72. SIEMENS Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. SIEMENS Main Business
Table 74. SIEMENS Latest Developments
Table 75. Lantheus Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 76. Lantheus Nuclear Medicine Product Offered
Table 77. Lantheus Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Lantheus Main Business
Table 79. Lantheus Latest Developments
Table 80. Bracco Imaging Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 81. Bracco Imaging Nuclear Medicine Product Offered
Table 82. Bracco Imaging Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Bracco Imaging Main Business
Table 84. Bracco Imaging Latest Developments
Table 85. Bayer Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 86. Bayer Nuclear Medicine Product Offered
Table 87. Bayer Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Bayer Main Business
Table 89. Bayer Latest Developments
Table 90. Eli Lilly Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 91. Eli Lilly Nuclear Medicine Product Offered
Table 92. Eli Lilly Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Latest Developments
Table 95. Aurobindo Pharma Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 96. Aurobindo Pharma Nuclear Medicine Product Offered
Table 97. Aurobindo Pharma Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Aurobindo Pharma Main Business
Table 99. Aurobindo Pharma Latest Developments
Table 100. Mundipharma Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 101. Mundipharma Nuclear Medicine Product Offered
Table 102. Mundipharma Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Mundipharma Main Business
Table 104. Mundipharma Latest Developments
Table 105. China Isotope & Radiation Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 106. China Isotope & Radiation Nuclear Medicine Product Offered
Table 107. China Isotope & Radiation Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. China Isotope & Radiation Main Business
Table 109. China Isotope & Radiation Latest Developments
Table 110. Yantai Dongcheng Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 111. Yantai Dongcheng Nuclear Medicine Product Offered
Table 112. Yantai Dongcheng Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Yantai Dongcheng Main Business
Table 114. Yantai Dongcheng Latest Developments
Table 1. Nuclear Medicine Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nuclear Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Diagnostic Nuclear Medicine
Table 4. Major Players of Therapeutic Nuclear Medicine
Table 5. Nuclear Medicine Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Nuclear Medicine Market Size Market Share by Type (2020-2025)
Table 8. Nuclear Medicine Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Nuclear Medicine Market Size Market Share by Application (2020-2025)
Table 11. Global Nuclear Medicine Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Nuclear Medicine Revenue Market Share by Player (2020-2025)
Table 13. Nuclear Medicine Key Players Head office and Products Offered
Table 14. Nuclear Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nuclear Medicine Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Nuclear Medicine Market Size Market Share by Region (2020-2025)
Table 19. Global Nuclear Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Nuclear Medicine Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Nuclear Medicine Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Nuclear Medicine Market Size Market Share by Country (2020-2025)
Table 23. Americas Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Nuclear Medicine Market Size Market Share by Type (2020-2025)
Table 25. Americas Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Nuclear Medicine Market Size Market Share by Application (2020-2025)
Table 27. APAC Nuclear Medicine Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Nuclear Medicine Market Size Market Share by Region (2020-2025)
Table 29. APAC Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Nuclear Medicine Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Nuclear Medicine Market Size Market Share by Country (2020-2025)
Table 33. Europe Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Nuclear Medicine Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Nuclear Medicine Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Nuclear Medicine Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Nuclear Medicine
Table 39. Key Market Challenges & Risks of Nuclear Medicine
Table 40. Key Industry Trends of Nuclear Medicine
Table 41. Global Nuclear Medicine Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Nuclear Medicine Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Nuclear Medicine Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Nuclear Medicine Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Cardinal Health Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 46. Cardinal Health Nuclear Medicine Product Offered
Table 47. Cardinal Health Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Cardinal Health Main Business
Table 49. Cardinal Health Latest Developments
Table 50. GE Healthcare Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 51. GE Healthcare Nuclear Medicine Product Offered
Table 52. GE Healthcare Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. GE Healthcare Main Business
Table 54. GE Healthcare Latest Developments
Table 55. Jubilant Pharma Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 56. Jubilant Pharma Nuclear Medicine Product Offered
Table 57. Jubilant Pharma Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Jubilant Pharma Main Business
Table 59. Jubilant Pharma Latest Developments
Table 60. Novartis Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 61. Novartis Nuclear Medicine Product Offered
Table 62. Novartis Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Curium Pharma Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 66. Curium Pharma Nuclear Medicine Product Offered
Table 67. Curium Pharma Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Curium Pharma Main Business
Table 69. Curium Pharma Latest Developments
Table 70. SIEMENS Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 71. SIEMENS Nuclear Medicine Product Offered
Table 72. SIEMENS Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. SIEMENS Main Business
Table 74. SIEMENS Latest Developments
Table 75. Lantheus Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 76. Lantheus Nuclear Medicine Product Offered
Table 77. Lantheus Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Lantheus Main Business
Table 79. Lantheus Latest Developments
Table 80. Bracco Imaging Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 81. Bracco Imaging Nuclear Medicine Product Offered
Table 82. Bracco Imaging Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Bracco Imaging Main Business
Table 84. Bracco Imaging Latest Developments
Table 85. Bayer Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 86. Bayer Nuclear Medicine Product Offered
Table 87. Bayer Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Bayer Main Business
Table 89. Bayer Latest Developments
Table 90. Eli Lilly Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 91. Eli Lilly Nuclear Medicine Product Offered
Table 92. Eli Lilly Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Latest Developments
Table 95. Aurobindo Pharma Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 96. Aurobindo Pharma Nuclear Medicine Product Offered
Table 97. Aurobindo Pharma Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Aurobindo Pharma Main Business
Table 99. Aurobindo Pharma Latest Developments
Table 100. Mundipharma Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 101. Mundipharma Nuclear Medicine Product Offered
Table 102. Mundipharma Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Mundipharma Main Business
Table 104. Mundipharma Latest Developments
Table 105. China Isotope & Radiation Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 106. China Isotope & Radiation Nuclear Medicine Product Offered
Table 107. China Isotope & Radiation Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. China Isotope & Radiation Main Business
Table 109. China Isotope & Radiation Latest Developments
Table 110. Yantai Dongcheng Details, Company Type, Nuclear Medicine Area Served and Its Competitors
Table 111. Yantai Dongcheng Nuclear Medicine Product Offered
Table 112. Yantai Dongcheng Nuclear Medicine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Yantai Dongcheng Main Business
Table 114. Yantai Dongcheng Latest Developments
LIST OF FIGURES
Figure 1. Nuclear Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclear Medicine Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nuclear Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nuclear Medicine Sales Market Share by Country/Region (2024)
Figure 8. Nuclear Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nuclear Medicine Market Size Market Share by Type in 2024
Figure 10. Nuclear Medicine in Oncology
Figure 11. Global Nuclear Medicine Market: Oncology (2020-2025) & ($ millions)
Figure 12. Nuclear Medicine in Thyroid
Figure 13. Global Nuclear Medicine Market: Thyroid (2020-2025) & ($ millions)
Figure 14. Nuclear Medicine in Cardiology
Figure 15. Global Nuclear Medicine Market: Cardiology (2020-2025) & ($ millions)
Figure 16. Nuclear Medicine in Others
Figure 17. Global Nuclear Medicine Market: Others (2020-2025) & ($ millions)
Figure 18. Global Nuclear Medicine Market Size Market Share by Application in 2024
Figure 19. Global Nuclear Medicine Revenue Market Share by Player in 2024
Figure 20. Global Nuclear Medicine Market Size Market Share by Region (2020-2025)
Figure 21. Americas Nuclear Medicine Market Size 2020-2025 ($ millions)
Figure 22. APAC Nuclear Medicine Market Size 2020-2025 ($ millions)
Figure 23. Europe Nuclear Medicine Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Nuclear Medicine Market Size 2020-2025 ($ millions)
Figure 25. Americas Nuclear Medicine Value Market Share by Country in 2024
Figure 26. United States Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Nuclear Medicine Market Size Market Share by Region in 2024
Figure 31. APAC Nuclear Medicine Market Size Market Share by Type (2020-2025)
Figure 32. APAC Nuclear Medicine Market Size Market Share by Application (2020-2025)
Figure 33. China Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 37. India Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Nuclear Medicine Market Size Market Share by Country in 2024
Figure 40. Europe Nuclear Medicine Market Size Market Share by Type (2020-2025)
Figure 41. Europe Nuclear Medicine Market Size Market Share by Application (2020-2025)
Figure 42. Germany Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 43. France Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Nuclear Medicine Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Nuclear Medicine Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Nuclear Medicine Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 56. APAC Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 57. Europe Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 59. United States Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 60. Canada Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 61. Mexico Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 62. Brazil Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 63. China Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 64. Japan Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 65. Korea Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 67. India Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 68. Australia Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 69. Germany Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 70. France Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 71. UK Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 72. Italy Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 73. Russia Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 74. Egypt Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 75. South Africa Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 76. Israel Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 77. Turkey Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 78. Global Nuclear Medicine Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Nuclear Medicine Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 1. Nuclear Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclear Medicine Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nuclear Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nuclear Medicine Sales Market Share by Country/Region (2024)
Figure 8. Nuclear Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nuclear Medicine Market Size Market Share by Type in 2024
Figure 10. Nuclear Medicine in Oncology
Figure 11. Global Nuclear Medicine Market: Oncology (2020-2025) & ($ millions)
Figure 12. Nuclear Medicine in Thyroid
Figure 13. Global Nuclear Medicine Market: Thyroid (2020-2025) & ($ millions)
Figure 14. Nuclear Medicine in Cardiology
Figure 15. Global Nuclear Medicine Market: Cardiology (2020-2025) & ($ millions)
Figure 16. Nuclear Medicine in Others
Figure 17. Global Nuclear Medicine Market: Others (2020-2025) & ($ millions)
Figure 18. Global Nuclear Medicine Market Size Market Share by Application in 2024
Figure 19. Global Nuclear Medicine Revenue Market Share by Player in 2024
Figure 20. Global Nuclear Medicine Market Size Market Share by Region (2020-2025)
Figure 21. Americas Nuclear Medicine Market Size 2020-2025 ($ millions)
Figure 22. APAC Nuclear Medicine Market Size 2020-2025 ($ millions)
Figure 23. Europe Nuclear Medicine Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Nuclear Medicine Market Size 2020-2025 ($ millions)
Figure 25. Americas Nuclear Medicine Value Market Share by Country in 2024
Figure 26. United States Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Nuclear Medicine Market Size Market Share by Region in 2024
Figure 31. APAC Nuclear Medicine Market Size Market Share by Type (2020-2025)
Figure 32. APAC Nuclear Medicine Market Size Market Share by Application (2020-2025)
Figure 33. China Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 37. India Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Nuclear Medicine Market Size Market Share by Country in 2024
Figure 40. Europe Nuclear Medicine Market Size Market Share by Type (2020-2025)
Figure 41. Europe Nuclear Medicine Market Size Market Share by Application (2020-2025)
Figure 42. Germany Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 43. France Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Nuclear Medicine Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Nuclear Medicine Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Nuclear Medicine Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Nuclear Medicine Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 56. APAC Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 57. Europe Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 59. United States Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 60. Canada Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 61. Mexico Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 62. Brazil Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 63. China Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 64. Japan Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 65. Korea Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 67. India Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 68. Australia Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 69. Germany Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 70. France Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 71. UK Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 72. Italy Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 73. Russia Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 74. Egypt Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 75. South Africa Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 76. Israel Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 77. Turkey Nuclear Medicine Market Size 2026-2031 ($ millions)
Figure 78. Global Nuclear Medicine Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Nuclear Medicine Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Nuclear Medicine Market Size 2026-2031 ($ millions)
More Publications
Global Hyperpigmentation Treatment Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2024
108 pages
Global Levothyroxine Sodium Market Growth 2025-2031
US$ 3,660.00
January 2025
90 pages
Global Contract Research Organization (CRO) Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
118 pages
Global Targeted Delivery Drugs Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
103 pages
